UQUIFA, a company that manufactures APIs and intermediates for the pharmaceutical and animal health industry, has joined the IQS Business Foundation as a new member.
UQUIFA, a company that manufactures APIs and intermediates for the pharmaceutical and animal health industry, has joined the IQS Business Foundation as a new member. The company's membership in the IQS Business Foundation was formalized through an institutional event held on 21 November at the IQS campus. The event was attended by UQUIFA representatives Saurabh Gurnurkar, Managing Director, Pilar Valle, Financial Director, and Susana Anguera, HR Manager. On behalf of IQS, Dr Salvador Borrós, Director of IQS, and Rosa Curt, Director of the IQS Business Foundation, were present.
The UQUIFA Group is a small molecule API (active pharmaceutical ingredient) development and manufacturing company based in Barcelona. Founded in 1936, the UQUIFA Group currently serves a global customer base from its factories in Spain, Mexico, and Hungary through the patent-free CDMO and API business lines. It focuses on providing value through its development and manufacturing capabilities to its customer base in the specialized pharmaceutical and chemical industry, with the US, EU, and Japan as its leading markets.
The UQUIFA Group boasts a team of around 750 people and has an international customer base in 70 countries. R&D and innovation are firmly at the core of the company's strategy. The group makes ongoing investments in personnel, plant facilities, and processes to remain at the forefront of technology.